A Multi-Country Study of the Clinical Course of Extensive-Stage Small Cell Lung Cancer: A Six-Study Analysis of Real-World Treatment Patterns and Outcomes.
(2025)
Clin Epidemiol 17(): 1117-1129
Pundole X, Younan D, Critchlow CW, Puntis SR, Soohoo M, Anderson ES, Najdi R, Horinouchi H, Calvo V, Cobo M, Lopez-Castro R, Bernabe R, Cho J, Desai PA, Ahn MJ, Provencio M

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence.
(2025 Apr)
Clin Pharmacol Ther 117(4): 927-937
Hernandez RK, Critchlow CW, Dreyer N, Lash TL, Reynolds RF, Sørensen HT, Lange JL, Gatto NM, Sobel RE, Lai EC, Schoonen M, Brown JS, Christian JB, Brookhart MA, Bradbury BD

Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative review.
(2023 Jun)
Pharmacoepidemiol Drug Saf 32(6): 599-606
Levintow SN, Nielson CM, Hernandez RK, Breskin A, Pritchard D, Lash TL, Rothman KJ, Gilbertson D, Muntner P, Critchlow C, Brookhart MA, Bradbury BD

Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort study.
(2022 Feb 28)
BMJ Open 12(2): e055137
Page JH, Londhe AA, Brooks C, Zhang J, Sprafka JM, Bennett C, Braunlin M, Brown CA, Charuworn P, Cheng A, Gill K, He F, Ma J, Petersen J, Ayodele O, Bao Y, Carlson KB, Chang SC, Devercelli G, Jonsson-Funk M, Jiang J, Keenan HA, Ren K, Roehl KA, Sanders L, Wang L, Wei Z, Xia Q, Yu P, Zhou L, Zhu J, Gondek K, Critchlow CW, Bradbury BD

Machine learning applications for therapeutic tasks with genomics data.
(2021 Oct 8)
Patterns (N Y) 2(10): 100328
Huang K, Xiao C, Glass LM, Critchlow CW, Gibson G, Sun J